Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis

Human Mutation

Volumn 7, Issue 2, 1996, Pages 100-104

  Peacock, Michael L ^a   Borst, Marilyn J ^a   Sweet, Jason D ^a   Decker, Ruth A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

DGGE; FMTC; MEN 2a; RET proto oncogene

Indexed keywords

ARTICLE; CANCER GENETICS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FAMILIAL CANCER; GENE AMPLIFICATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

BASE SEQUENCE; CARCINOMA, MEDULLARY; DNA PRIMERS; DROSOPHILA PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXONS; HUMANS; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NUCLEIC ACID DENATURATION; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; UREA;

EID: 0029919364     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1996)7:2<100::AID-HUMU2>3.0.CO;2-G     Document Type: Article

References (14)

1. Borst M, Van Camp J, Peacock M, Decker R (1995) Mutational analysis of multiple endocrine neoplasia type 2a associated with Hischsprung's disease. Surgery 117:386-391.
2. Decker R (1992) Long-term follow-up of a large North American kindred with multiple endocrine neoplasia type 2a. Surgery 112:1066-1073.
3. Decker R, Peacock M, Borst M, Sweet J, Thompson N (1995) Progress in genetic screening of MEN 2a: Is calcitonin testing obsolete? Surgery 118:257-264.
4. Donis-Keller H, Dou S, Chi D, Carlson K, Toshima K, Lairmore T, Howe J, Moley J, Goodfellow P, Wells S (1993) Mutations in the RET proto-oncogene are associated with MEN 2a and FMTC. Hum Mol Genet 2:851-856.
5. Eng C, Smith D, Mulligan L, Healey C, Zvelebil M, Stonehouse T, Ponder M, Jackson C, Waterfield M, Ponder B (1995) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509-513.
6. Fischer SO, Lerman LS (1983) DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory. Proc Natl Acad Sci USA 80:1579-1583.
7. Itoh F, Ishizaka Y, Tahira T, Yamamoto M, Miya A, Imai K, Yachi A, Takai S, Sugimura T, Nagao M (1992) Identification and analysis of theret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN 2A patients. Oncogene 7:1201-1206.
8. Kwok J, Gardner E, Warner J, Ponder B, Mulligan L (1993) Structural analysis of the human RET proto-oncogene using exon trapping. Oncogene 8:2575-2582.
9. Lerman L, Silverstein K (1987) Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 155:482-501.
10. McMahon R, Mulligan L, Healey C, Payne S, Ponder M, Ferguson-Smith M, Barton D, Ponder B (1994) Direct, non-radioactive detection of mutations in Multiple Endocrine Neoplasia Type 2a families. Hum Mol Genet 3:643-646.
11. Mulligan L, Kwok J, Healey C, Eisdon M, Eng C, Gardner E, Love D, Mole S, Moore J, Papi L, Ponder M, Telenius H, Tunnacliffe A, Ponder B (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a. Nature 363:458-460.
12. Mulligan L, Eng C, Healey C, Clayton D, Kwok J, Gardner E, Ponder M, Frilling A, Jackson C, Lehnert H, Neumann H, Thobodeau S, Ponder B (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2a and FMTC. Nature Genet 6:70-74.
13. Wells S, Baylin S, Linehan W, Farrell R, Cox E, Cooper C (1978) Provocative agents and the diagnosis of medullary thyroid carcinoma of the thyroid gland. Ann Surg 188:139-141.
14. Xue F, Hong Y, Maurer L, Memoli V, Nutile-McMenemy N, Schuster M, Bowden D, Mao J, Noll W (1994) Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Hum Mol Genet 3:635-638.